Results: 278 clinical trials
A research study of a new investigational (experimental) drug called VB-111 to treat advanced metastatic cancer (cancer that has spread to other parts of the body) and we want to learn if VB-111 will have a good effect on the cancer, such as keeping the cancer cells from dividing and growing. "Investigational" means that VB-111 has not been approved by the Food and Drug Administration (FDA) for commercial use, sale or marketing.
Contact: Ellen Jones jonese5@uthscsa.edu 2104505863The purpose of this study is to evaluate the safety, tolerability and preliminary efficacy of elacestrant (RAD1901) in patients with advanced ER+, HER2-negative breast cancer.
Contact: Virginia Kaklamani kaklamani@uthscsa.edu 2104503838This study is being done to look at whether an agent that is commonly used to treat diabetes, Metformin, can decrease or affect the ability of breast cancer cells to grow and whether Metformin will work with another therapy to keep cancer from returning (recurring).
Contact: Patricia Devore devore@uthscsa.edu (210) 450-1233